Markers of bone metabolism in patients with chronic pancreatitis and pancreatic ductal adenocarcinoma

Medicine (United States)

Volumn 94, Issue 42, 2015, Pages e1754-

  Pezzilli, Raffaele ^a   Melzi D'Eril, Gian Vico ^b   Barassi, Alessandra ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; ELASTASE; FECAL ELASTASE 1; OSTEOCALCIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BONE METABOLISM; CALCIUM BLOOD LEVEL; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS ADENOCARCINOMA; PANCREAS EXOCRINE INSUFFICIENCY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; AGE; ANALOGS AND DERIVATIVES; BLOOD; BONE; CHRONIC DISEASE; COMPLICATION; DRINKING BEHAVIOR; EPIDEMIOLOGY; EXOCRINE PANCREATIC INSUFFICIENCY; LUMINESCENCE; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; SMOKING;

AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; BONE AND BONES; CALCIUM; CARCINOMA, PANCREATIC DUCTAL; CHRONIC DISEASE; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PARATHYROID HORMONE; SMOKING; VITAMIN D;

EID: 84947916274     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001754     Document Type: Article

References (26)

1. Pezzilli R, Andriulli A, Bassi C, et al., Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol. 2013;19:7930-7946.
2. Girgis CM, Baldock PA, Downes M. Vitamin D, muscle and bone: Integrating effects in development, aging and injury. Mol Cell Endocrinol. 2015;410:3-10.
3. Barassi A, Porreca W, De Pasquale L, et al. Use of intraoperative samples to optimize efficacy of central laboratory parathyroid hormone analyses. Clin Chem. 2007;53:535-536.
4. De Pasquale L, Gobatti D, Ravini ML, et al. Intra-operative testing for parathyroid hormone: The Central Laboratory option. J Endocrinol Invest. 2008;31:62-67.
5. Alselami NM, Noureldeen AF, Al-Ghamdi MA, et al. Bone turnover biomarkers in obese postmenopausal Saudi women with type-II diabetes mellitus. Afr Health Sci. 2015;15:90-96.
6. Franck H, Keck E. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis. 1993;52:343-346.
7. Fu SW, Zeng GF, Zong SH, et al. Systematic review and metaanalysis of the bone protective effect of phytoestrogens on osteoporosis in ovariectomized rats. Nutr Res. 2014;34:467-477.
8. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26:97-122.
9. Pezzilli R, Barassi A, Corsi MM, et al. Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Scand J Gastroenterol. 2010;45:93-99.
10. Pezzilli R, Barassi A, Morselli-Labate AM, et al. Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: A possible link between pancreatic insufficiency and intestinal inflammation. J Gastroenterol. 2007;42:754-760.
11. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894. Geneva, Switzerland: WHO Press; 2000.
12. Vashi P, Popiel B, Lammersfeld C, et al. Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer. Pancreas. 2015.
13. Joshi A, Reddy SV, Bhatia V, et al. High prevalence of low bone mineral density in patients with tropical calcific pancreatitis. Pancreas. 2011;40:762-767.
14. Duggan SN, O'Sullivan M, Hamilton S, et al. Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas. 2012;41:1119-1124.
15. Sikkens EC, Cahen DL, Koch AD, et al. The prevalence of fatsoluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013;13:238-242.
16. Haas S, Krins S, Knauerhase A, et al. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP. 2015;16:58-62.
17. Mann ST, Stracke H, Lange U, et al. Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis. Metabolism. 2003;52:579-585.
18. Duggan SN, Smyth ND, Murphy A, et al. High prevalence of osteoporosis in patients with chronic pancreatitis: A systematic review and meta-Analysis. Clin Gastroenterol Hepatol. 2014;12:219-228.
19. Duggan SN, Purcell C, Kilbane M, et al. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: A case-matched study. Am J Gastroenterol. 2015;110:336-345.
20. Piemonte S, Romagnoli E, Cipriani C, et al. Six-year follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia. Eur J Endocrinol. 2013;170:K1-4.
21. Liu SL, Zhao YP, Dai MH, et al. Vitamin D status and the risk of pancreatic cancer: A meta-Analysis. Chin Med J (Engl). 2013;126:3356-3359.
22. Zablotska LB, Gong Z, Wang F, et al. Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based casecontrol study in the San Francisco Bay area. Cancer Causes Control. 2011;22:91-100.
23. Li L, Wu B, Yang L, et al. Association of vitamin D receptor gene polymorphisms with pancreatic cancer: A pilot study in a North China Population. Oncol Lett. 2013;5:1731-1735.
24. Anderson LN, Cotterchio M, Knight JA, et al. Genetic variants in vitamin D pathway genes and risk of pancreas cancer; results from a population-based case-control study in Ontario, Canada. PLoS One. 2013;8:e66768.
25. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, et al. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: A nested case-control study. Cancer Res. 2012;72:1190-1198.
26. Vasikaran S, Cooper C, Eastell R, et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med. 2011;49:1271-1274.